Literature DB >> 15138189

Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.

Natividad Benito1, Asunción Moreno, Xavier Filella, José M Miró, Julià González, Tomás Pumarola, María Eugenia Valls, Montserrat Luna, Felipe García, Ana Rañó, Antoni Torres, José M Gatell.   

Abstract

We analyzed the characteristics of the inflammatory response occurring in blood during pulmonary infections in human immunodeficiency virus (HIV)-infected patients. A prospective study of consecutive hospital admissions of HIV-infected patients with new-onset radiologic pulmonary infiltrates was carried out in a tertiary university hospital from April 1998 to May 2001. Plasma cyclic AMP receptor protein (CRP), interleukin 1beta (IL-1beta), IL-6, IL-8, IL-10, and tumor necrosis factor alpha (TNF-alpha) levels were determined at the time of admission and 4, 5, and 6 days later. Patients were included in a protocol addressed to study etiology and outcome of disease. A total of 249 episodes of infection were included, with the main diagnoses being bacterial pneumonia (BP) (118 episodes), Pneumocystis carinii pneumonia (PCP) (41 episodes), and mycobacteriosis (36 episodes). For these three patient groups, at the time of admission the median CRP and cytokine levels were as follows: CRP, 10.2, 3.8 and 5 mg/dl, respectively (P = 0.0001); IL-8, 19, 3, and 2.9 pg/ml (P = 0.045); and TNF-alpha, 46.4, 44, and 75 pg/ml, respectively (P = 0.029). There were no significant differences in levels of IL-1beta, IL-6, or IL-10 among the patient groups. A total of 23 patients died. At the time of admission, HIV-infected patients with BP had higher plasma CRP and IL-8 levels than did PCP and mycobacteriosis patients. TNF-alpha levels were higher in patients with mycobacteriosis. An elevated IL-8 level (>61 pg/ml) at the time of admission was an independent factor associated with higher mortality (odds ratio, 12; 95% confidence interval, 1.2 to 235.5).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138189      PMCID: PMC404570          DOI: 10.1128/CDLI.11.3.608-614.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  27 in total

Review 1.  The many faces of host responses to tuberculosis.

Authors:  H L Collins; S H Kaufmann
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain.

Authors:  N Benito; A Rañó; A Moreno; J González; M Luna; C Agustí; C Danés; T Pumarola; J M Miró; A Torres; J M Gatell
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

3.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

4.  Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha.

Authors:  F G Imperiali; A Zaninoni; L La Maestra; P Tarsia; F Blasi; W Barcellini
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 5.  Host factors in the pathogenesis of HIV disease.

Authors:  O J Cohen; A Kinter; A S Fauci
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

6.  Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls.

Authors:  T T Bauer; C Montón; A Torres; H Cabello; X Fillela; A Maldonado; J M Nicolás; E Zavala
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 7.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

8.  Compartmentalized cytokine production within the human lung in unilateral pneumonia.

Authors:  M S Dehoux; A Boutten; J Ostinelli; N Seta; M C Dombret; B Crestani; M Deschenes; J L Trouillet; M Aubier
Journal:  Am J Respir Crit Care Med       Date:  1994-09       Impact factor: 21.405

9.  Phagocyte function and cytokine production in community acquired pneumonia.

Authors:  K Moussa; H J Michie; I A Cree; A C McCafferty; J H Winter; D P Dhillon; S Stephens; R A Brown
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

10.  Levels of IL-8 and myeloperoxidase in the lungs of pneumonia patients.

Authors:  H Abul; A Abul; I Khan; T C Mathew; A Ayed; E Al-Athary
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

View more
  8 in total

1.  Factor VIII concentration is greater in female than male patients with HIV infection.

Authors:  Alireza Abdollahi; Afsaneh Morteza; Omid Khalilzadeh; Ahmad Ahmadzadeh
Journal:  Int J Hematol       Date:  2010-12-15       Impact factor: 2.490

2.  Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects.

Authors:  C Preston Neff; Jennifer L Chain; Samantha MaWhinney; Allison K Martin; Derek J Linderman; Sonia C Flores; Thomas B Campbell; Brent E Palmer; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

3.  Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.

Authors:  David R Boulware; Katherine Huppler Hullsiek; Camille E Puronen; Adam Rupert; Jason V Baker; Martyn A French; Paul R Bohjanen; Richard M Novak; James D Neaton; Irini Sereti
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

4.  Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patients.

Authors:  S Camon; C Quiros; N Saubi; A Moreno; M A Marcos; Y Eto; S Rofael; E Monclus; J Brown; T D McHugh; J Mallolas; R Perello
Journal:  BMC Infect Dis       Date:  2018-04-19       Impact factor: 3.090

5.  The innate immune response in HIV/AIDS septic shock patients: a comparative study.

Authors:  Rodrigo T Amancio; Andre M Japiassu; Rachel N Gomes; Emersom C Mesquita; Edson F Assis; Denise M Medeiros; Beatriz Grinsztejn; Patrícia T Bozza; Hugo C Castro-Faria Neto; Fernando A Bozza
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

6.  Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia.

Authors:  Jia Sun; Junwei Su; Yirui Xie; Michael T Yin; Ying Huang; Lijun Xu; Qihui Zhou; Biao Zhu
Journal:  J Immunol Res       Date:  2016-08-07       Impact factor: 4.818

7.  C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study.

Authors:  Fiona Mendelson; Rulan Griesel; Nicki Tiffin; Molebogeng Rangaka; Andrew Boulle; Marc Mendelson; Gary Maartens
Journal:  BMC Infect Dis       Date:  2018-08-14       Impact factor: 3.090

8.  [Human immunodeficiency virus-infected patients with community-acquired pneumonia: implication of respiratory viruses].

Authors:  Rafael Perelló; Asunción Moreno; Marta Camps; Carlos Cervera; Laura Linares; Tomás Pumarola; María Angeles Marcos
Journal:  Enferm Infecc Microbiol Clin       Date:  2008-02       Impact factor: 1.731

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.